Ehsan Sayed

Ehsan Sayed has a strong background in business development, particularly in the pharmaceutical industry. Ehsan joined Chefaa in 2019 as a Business Development Executive, where they played a crucial role in expanding the company's partnerships with various industry stakeholders, including Sanofi, Bayer, GSK, Eva Pharma, and Nivea. Their efforts were instrumental in serving more patients and driving growth for the company. In 2022, Ehsan was promoted to the position of Senior Business Development Specialist, where they continued to build relationships with key stakeholders to further enhance Chefaa's reach and impact in the healthcare industry.

Ehsan Sayed completed their Bachelor's degree in Computer Engineering from Cairo University, where they studied in the Faculty of Engineering, Computer Engineering Department from 2015 to 2019. In 2018 and 2019, they also pursued a Non-Degree program in Business Administration and Management for a duration of six months or one semester at The American University in Cairo.

Additionally, Ehsan obtained several certifications, including "Marketing Foundations: Ecommerce," "Excel: Creating Business Budgets," "Learning LinkedIn Sales Navigator," "Programmatic Advertising Foundations," "Google Sheets Essential Training," "Collaboration Principles and Process," "Sales Operations," "Strategic Partnerships," "Aligning Sales and Marketing," "Business-to-Business Sales," "Craft Your Sales Pitch with Competitive Differentiation," "Google Ads (AdWords) Essential Training," "Lead Generation Foundations," "Writing a Proposal," "Advanced Business Development: Communication and Negotiation," "Asking Great Sales Questions," "Business Analysis Foundations," "Business Development Foundations: Researching Market and Customer Needs," "Initiating and Planning Projects," and "Market Research Foundations." These certifications were obtained from LinkedIn, except for the certification in "Initiating and Planning Projects," which was obtained from Coursera. The certifications were earned between February 2020 and March 2022.